COVID-19 vaccine-induced VITT/TSS in Malaysia

Excerpt

Thrombosis with thrombocytopenia (Vaccine-Induced Immune Thrombotic Thrombocytopenia [VITT], also known as Thrombosis with Thrombocytopenia syndrome [TTS]) has been reported mostly after doses of AstraZeneca COVID-19 vaccine [AZD-1222] and Janssen COVID-19 vaccine [Ad26.COV2-S] internationally, and has been reported after use of the AstraZeneca vaccine and Pfizer-BioNTech COVID-19 vaccine [tozanimeran, Comirnaty] in Malaysia, says the Malaysian National Pharmaceutical Regulatory Agency (NPRA). The Janssen COVID-19 vaccine is not currently available in Malaysia. …